No involvement of APC gene mutations in ulcerative colitis-associated rat colon carcinogenesis induced by 1-hydroxyanthraquinone and methylazoxymethanol acetate

Molecular Carcinogenesis

Volumn 20, Issue 4, 1997, Pages 389-393

  Suzui, Masumi ^a   Ushijima, Toshikazu ^a   Yoshimi, Naoki ^b   Nakagama, Hitoshi ^a   Hara, Akira ^b   Sugimura, Takashi ^a   Nagao, Minako ^a   Mori, Hideki ^b  

^a NATIONAL CANCER CENTER RESEARCH INSTITUTE   (Japan)

^b GIFU UNIVERSITY   (Japan)

Author keywords

1 hydroxyanthraquinone; APC; Methylazoxymethanol acetate; Rat colitis associated colon carcinogenesis

Indexed keywords

ANTHRAQUINONE DERIVATIVE; METHYLAZOXYMETHANOL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER RISK; CARCINOGENIC ACTIVITY; COLON CARCINOGENESIS; COLON CARCINOMA; DISEASE ASSOCIATION; DRUG EFFECT; GENE MUTATION; MALE; NONHUMAN; ONCOGENE K RAS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RAT; SINGLE STRAND CONFORMATION POLYMORPHISM; ULCERATIVE COLITIS;

ANIMALS; ANTHRAQUINONES; BASE SEQUENCE; CARCINOGENS; COLITIS, ULCERATIVE; COLONIC NEOPLASMS; DISEASE MODELS, ANIMAL; DNA PRIMERS; GENES, APC; GENES, RAS; HUMANS; MALE; METHYLAZOXYMETHANOL ACETATE; MUTAGENESIS; POLYMERASE CHAIN REACTION; POLYMORPHISM, SINGLE-STRANDED CONFORMATIONAL; RATS; RATS, INBRED F344;

ANIMALIA;

EID: 0031416890     PISSN: 08991987     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1098-2744(199712)20:4<389::AID-MC8>3.0.CO;2-E     Document Type: Article

References (40)

1. Riddell R, Goldman H, Ransohoff D, et al. Dysplasia in inflammatory bowel disease: Standardized classification with provisional clinical applications. Hum Pathol 14:931-968, 1983.
2. Benhattar J, Saraga E. Molecular genetics of dysplasia in ulcerative colitis. Eur J Cancer 31A:1171-1173, 1995.
3. Yin J, Harpaz N, Tong Y, et al. p53 point mutations in dysplastic and cancerous ulcerative colitis lesions. Gastroenterology 104:1633-1639, 1993.
4. Kern S, Redston M, Seymour A, et al. Molecular genetic profiles of colitis-associated neoplasms. Gastroenterology 107:420-428, 1994.
5. Redston M, Papadopoulos N, Caldas C, Kinzler K, Kern S. Common occurrence of APC and Ki-ras mutations in the spectrum of colitis-associated neoplasms. Gastroenterology 108:383-392, 1995.
6. Tarmin L, Yin J, Harpaz N, et al. Adenomatous polyposis coli gene mutations in ulcerative colitis-associated dysplasias and cancers versus sporadic colon neoplasms. Cancer Res 55:2035-2038, 1995.
7. Bell S, Kelly S, Hoyle J, et al. c-Kis-ras gene mutations in dysplasia and carcinomas complicating ulcerative colitis. Br J Cancer 64:174-178, 1991.
8. Burmer G, Levine D, Kulander B, Haggitt R, Rubin C, Ravinovitch P. C-Ki-ras mutations in chronic ulcerative colitis and sporadic colon carcinoma. Gastroenterology 99:416-420, 1990.
9. Chaubert P, Benhattar J, Saraga E, Costa J. K-ras mutations and p53 alterations in neoplastic and nonneoplastic lesions associated with longstanding ulcerative colitis. Am J Pathol 144:767-775, 1994.
10. Meltzer S, Mane S, Wood P, et al. Activation of c-Ki-ras in human gastrointestinal dysplasias determined by direct sequencing of polymerase chain reaction products. Cancer Res 50:3627-3630, 1990.
11. Mori H, Yoshimi N, Iwata H, et al. Carcinogenicity of naturally occurring 1-hydroxyanthraquinone in rats: Induction of large bowel, liver and stomach neoplasms. Carcinogenesis 11:799-802, 1990.
12. Mori H, Mon Y, Tanaka T, et al. Cell kinetic analysis of the mucosal epithelium and assay of ornithine decarboxylase activity during the process of 1-hydroxyanthraquinone-induced large bowel carcinogenesis in rats. Carcinogenesis 13:2217-2220, 1992.
13. Mori Y, Yoshimi N, Iwata H, Tanaka T, Mori H. The synergistic effect of 1-hydroxyanthraquinone on methylazoxymethanol acetate-induced carcinogenesis in rats. Carcinogenesis 12:335-338, 1991.
14. Suzui M, Yoshimi N, Ushijima T, et al. No involvement of Ki-ras or p53 gene mutations in colitis-associated rat colon tumors induced by 1-hydroxyanthraquinone and methylazoxymethanol acetate. Mol Carcinog 12:193-197, 1995.
15. Blin N, Stafford D. A general method for isolation of high molecular weight DNA from eukaryotes. Nucleic Acids Res 3:2303-2308, 1976.
16. Kakiuchi H, Watanabe M, Ushijima T, et al. Specific 5'-GGGA-3'→5'-GGA-3' mutation of the Apc gene in rat colon tumors induced by 2-amino-1-methyl-6-phenylimidazo [4,5-b] pyridine. Proc Natl Acad Sci USA 92:910-914, 1995.
17. Orita M, Suzuki Y, Hayashi K. Rapid and sensitive detection of point mutation and DNA polymorphisms using the polymerase chain reaction. Genomics 5:874-879, 1989.
18. Ushijima T, Hosoya Y, Suzuki T, Sofuni T, Sugimura T, Nagao M. A rapid method for detection of mutations in the lacl gene using PCR-single strand conformation polymorphism analysis: Demonstration of its high sensitivity. Mutat Res 334:283-292, 1995.
19. Hayashi K, Yandel D. How sensitive is PCR-SSCP? Hum Mutat 2:338-346, 1993.
20. Ushijima T, Hosoya Y, Ochiai M, et al. Tissue-specific mutational spectra of 2-amino-3,4-dimethylimidazo [4,5-f] quinoline in the liver and bone marrow of lad transgenic mice. Carcinogenesis 15:2805-2809, 1994.
21. Lennard-Jones J, Morson B, Ritchie J, Shove D, Williams C. Cancer in colitis: Assessment of the individual risk by clinical and histological criteria. Gastroenterology 73:1280-1289, 1977.
22. Yardley J, Keren D. "Precancer" lesions in ulcerative colitis: A retrospective study of rectal biopsy and colectomy specimens. Cancer 34:835-841, 1974.
23. Serafini E, Kirk A, Chambers T. Rate and pattern of epithelial cell proliferation in ulcerative colitis. Gut 22:648-652, 1981.
24. Powell S, Zilz N, Barclay Y, et al. APC mutations occur early during colorectal tumorigenesis. Nature 359:235-237, 1992.
25. Miyaki M, Konishi M, Kikuchi-Yanoshita R, et al. Characteristics of somatic mutation of the adenomatous polyposis coli gene in colorectal tumors. Cancer Res 54:3011-3020, 1994.
26. Miyoshi Y, Nagase H, Ando H, et al. Somatic mutations of the APC gene in colorectal tumors: Mutation cluster region in the APC gene. Hum Mol Genet 1:229-233, 1992.
27. Vogelstein B, Fearon E, Hamilton S, et al. Genetic alterations during colorectal-tumor development. N Engl J Med 319:525-532, 1988.
28. Fearon E, Vogelstein B. A genetic model for colorectal tumorigenesis. Cell 61:759-767, 1990.
29. Burmer G, Rabinovitch P, Haggitt R, et al. Neoplastic progression in ulcerative colitis: Histology, DNA content, and loss of a p53 allele. Gastroenterology 103:1602-1610, 1992.
30. Makino H, Ushijima T, Kakiuchi H, et al. Absence of p53 mutations in rat colon tumors induced by 2-amino-6-methyldipydio [1,2-a: 3',2'-d] imidazole, 2-amino-3-methylimidazo [4,5-f] quinoline, or 2-amino-1-methyl-6-phenylimidazo [4,5-b] pyridine. Jpn J Cancer Res 85:510-514, 1994.
31. Shivapurkar N, Belinsky S, Wolf D, Tang Z, Alabaster O. Absence of p53 gene mutations in rat colon carcinomas induced by azoxymethane. Cancer Lett 96:63-70, 1995.
32. Kakiuchi H, Ushijima T, Ochiai M, et al. Rare frequency of activation of Ki-ras gene in rat colon tumors induced by heterocyclic amines: Possible alternative mechanisms of human colon carcinogenesis. Mol Carcinog 8:44-48, 1993.
33. Reddy B, Narisawa T, Wright P, Vukusich D, Weisburger J, Wynder E. Colon carcinogenesis with azoxymethane and dimethylhydrazine in germ-free rats. Cancer Res 35:287-290, 1975.
34. Reddy B, Watanabe K, Weisburger J. Effect of high-fat diet on colon carcinogenesis in F344 rats treated with 1,2-dimethylhydrazine, methylazoxymethanol acetate, or methylnitrosourea. Cancer Res 37:4156-4159, 1977.
35. Jacoby R, Llor X, Teng B, Davidson N, Brasitus T. Mutations in the K-ras oncogene induced by 1,2-dimethylhydrazine in preneoplastic and neoplastic rat colonic mucosa. J Clin Invest 87:624-630, 1990.
36. Yoshimi N, Sato S, Makita H, et al. Expression of cytokines, TNF-α and IL-1α in MAM acetate and 1-hydroxyanthraquinone-induced colon carcinogenesis of rats. Carcinogenesis 15:783-785, 1994.
37. Liu B, Nicolaides N, Markowitz S, et al. Mismatch repair gene defects in sporadic colorectal cancers with microsatellite instability. Nat Genet 9:48-55, 1995.
38. + tumor cells. Cell 75:1227-1236, 1993.
39. Suzuki H, Harpaz N, Tarmin L, et al. Microsatellite instability in ulcerative colitis-associated colorectal dysplasias and cancers. Cancer Res 54:4841-4844, 1994.
40. Morin P, Sparks A, Korinek V, et al. Activation of β-catenin-Tcf signaling in colon cancer by mutations in β-catenin or APC. Science 275:1787-1790, 1997.